Sarcoidosis-associated pulmonary hypertension in patients with near-normal lung function

International Journal of Tuberculosis and Lung Disease

Volumn 17, Issue 3, 2013, Pages 406-411

  Maimon, N ^a   Salz, L ^a   Shershevsky, Y ^b   Matveychuk, A ^b,c   Guber, A ^b,c   Shitrit, D ^b,c  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b MEIR MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

6 minute walk distance test; Fibrosis; Near normal lung function; Pulmonary hypertension; Sarcoidosis

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG DIFFUSION CAPACITY; LUNG FIBROSIS; LUNG FUNCTION; LUNG SARCOIDOSIS; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; HYPERTENSION, PULMONARY; ISRAEL; LOGISTIC MODELS; LUNG; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULMONARY DIFFUSING CAPACITY; RETROSPECTIVE STUDIES; SARCOIDOSIS, PULMONARY; TERTIARY CARE CENTERS; TOMOGRAPHY, X-RAY COMPUTED; VITAL CAPACITY;

EID: 84874032516     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.12.0428     Document Type: Article

References (37)

1. Costabel U. Sarcoidosis: clinical update. Eur Respir J 2001; 32 (Suppl): 56s-68s.
2. Chaouat A, Bugnet A S, Kadaoui N, et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172: 189-194.
3. Chang B, Wigley F M, White B, Wise R A. Scleroderma patients with combined pulmonary hypertension and interstitial lung disease. J Rheumatol 2003; 30: 2398-2405.
4. Lettieri C J, Nathan S D, Barnett S D, Ahmad S, Shorr A F. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006; 129: 746-752.
5. Arcasoy S M, Christie J D, Pochettino A, et al. Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation. Chest 2001; 120: 873-880.
6. American Thoracic Society. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736-755.
7. Svanborg N. Studies on the cardiopulmonary function in sar-coidosis. Acta Med Scand 1961; 170 (Suppl): 39-114.
8. Gluskowski J, Hawrytkiewicz I, Zych D, et al. Pulmonary he-modynamics at rest and during exercise. Respiration 1984; 46: 26-32.
9. Emirgil C, Sobol B J, Herbert W H, et al. The lesser circulation in pulmonary fibrosis secondary to sarcoidosis and its relationship to respiratory function. Chest 1971; 60: 371-378.
10. Baughman R P, Gerson M, Bosken C H. Right and left ventricular function at rest and with exercise in patients with sar-coidosis. Chest 1984; 85: 301-306.
11. Sulica R, Teirstein A S, Kakarla S, Nemani N, Behnegar A, Padilla M L. Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension. Chest 2005; 128: 1483-1489.
12. Bourbonnais J M, Samavati L. Clinical predictors of pulmonary hypertension in sarcoidosis. Eur Respir J 2008; 32: 96-302.
13. Judson M A, Baughman R P, Teirstein A S, Terrin M L, Yeager H Jr. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A case-control etiologic study of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 75-86.
14. Scadding J G. Prognosis of intrathoracic sarcoidosis in England: a review of 136 cases after five years' observation. Br Med J 1961; 2: 1165-1172.
15. Austin J H, Müller N L, Friedman P J, Hansell D M, Naidich D P, Remy-Jardin M. Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. Radiology 1996; 200: 327-331.
16. Alhamad E H, Al-Boukai A A, Al-Kassimi F A, et al. Prediction of pulmonary hypertension in patients with or without interstitial lung disease: reliability of CT findings. Radiology 2011; 260: 875-883.
17. Standardization of spirometry. 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152: 1107-1136.
18. American Thoracic Society. Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS Statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117.
19. Yock P G, Popp R L. Non-invasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 1984; 70: 657-662.
20. Diaz-Guzman E, Vadi S, Minai O, et al. Safety of diagnostic bronchoscopy in patients with pulmonary hypertension. Respiration 2009; 77: 292-297.
21. Carmosino M J, Friesen R H, Doran A, Ivy D D. Peri-operative complications in children with pulmonary hypertension undergoing non-cardiac surgery or cardiac catheterization. Anesth Analg 2007; 104: 521-527.
22. Lai H C, Wang K Y, Lee W L, Ting C T, Liu T J. Severe pulmonary hypertension complicates postoperative outcome of non-cardiac surgery. Br J Anaesth 2007; 99: 184-190.
23. Longcope W T, Frieman D G. A study of sarcoidosis. Medicine (Baltimore) 1952; 31: 1-132.
24. McClement J. Cardiopulmonary function in the pulmonary form of Boek's sarcoid and its modification by cortisone therapy. Am Rev Tuberc Pulm Dis 1953; 67: 154-172.
25. Scadding J G. Sarcoidosis. 1st ed. London, UK: Eyre and Spottiswoode, 1967: pp 302-310.
26. Sones M, Israel H L. Course and prognosis of sarcoidosis. Am J Med 1960; 29: 84-93.
27. Maycock R L. Manifestations of sarcoidosis. Am J Med 1963; 35: 67-89.
28. Baughman R P, Engel P J, Lower E E. Survival in sarcoidosis associated pulmonary hypertension. Chest 2010; 138: 1078-1085.
29. Shorr A F, Helman D L, Davies D V, Nathan S D. Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics. Eur Respir J 2005; 25: 783-788.
30. Handa T, Nagai S, Miki S, et al. Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest 2006; 129: 1246-1252.
31. Miller A, Teirstein A S, Chuang M T. The sequence of physiologic changes in pulmonary sarcoidosis: correlation with radiographic stages and response to therapy. Mt Sinai J Med 1977; 44: 852-865.
32. Levine B W, Saldana M, Hutter A M. Pulmonary hypertension in sarcoidosis. Am Rev Respir Dis 1971; 3: 413-417.
33. Baughman R P, Gerson M, Bosken C H. Right and left ventricular function at rest and with exercise in patients with sar-coidosis. Chest 1984; 85: 301-306.
34. Takemura T, Matsui Y, Oritsu O, et al. Pulmonary vascular involvement in sarcoidosis: granulomatous angiitis and micro-angiopathy in transbronchial lung biopsies. Virchows Arch Pathol Anat Histopathol 1991; 418: 361-368.
35. Shapiro S M, Oudiz R J, Cao T, et al. Primary pulmonary hypertension: improved long term effects and survival with continuous epoprostenol infusion. J Am Coll Cardiol 1997; 30: 343-349.
36. Berger M, Haimowitz A, Van Tosh A, et al. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J Am Coll Cardiol 1985; 6: 359-365.
37. Lanzarini L, Fontana A, Lucca E, Campana C, Klersly C. Non-invasive estimation of both systolic and diastolic pulmonary artery pressure from Doppler analysis of TR velocity spectrum in patients with chronic heart failure. Am Heart J 2002; 144: 1087-1094.